CLINICAL_TRIALS
trial_result
· 2014-08-29
Clinical Trial Update: Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome [Phase 2]
Summary
Phase 2 double-blind, placebo-controlled trial of oxytocin in Fragile X Syndrome completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29